{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:59:41Z","timestamp":1767859181744,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"DOI":"10.1186\/s12884-025-08501-3","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T12:18:09Z","timestamp":1764850689000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The blocking efficacy and safety of tenofovir disoproxil fumarate tablets on mother-to-child transmission in pregnant women with high serum HBV DNA load: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Qing","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shurong","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaohua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"issue":"1","key":"8501_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12985-021-01580-6","volume":"18","author":"R Xu","year":"2021","unstructured":"Xu R, Hu P, Li Y, Tian A, Li J, Zhu C. Advances in HBV infection and replication systems in vitro. Virol J. 2021;18(1):105.","journal-title":"Virol J"},{"key":"8501_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cca.2022.11.012","volume":"538","author":"Z Liu","year":"2023","unstructured":"Liu Z, Li Y, Wang Y, Bai X, Zhang Y. Exosomes in HBV infection. Clin Chim Acta. 2023;538:65\u20139.","journal-title":"Clin Chim Acta"},{"issue":"5","key":"8501_CR3","first-page":"314","volume":"99","author":"T Wilkins","year":"2019","unstructured":"Wilkins T, Sams R, Carpenter M. Hepatitis B: screening, prevention, diagnosis, and treatment. Am Fam Physician. 2019;99(5):314\u201323.","journal-title":"Am Fam Physician"},{"key":"8501_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens12091146","author":"A Jose-Abrego","year":"2023","unstructured":"Jose-Abrego A, Roman S, Laguna-Meraz S, Panduro A. Host and HBV interactions and their potential impact on clinical outcomes. Pathogens. 2023. https:\/\/doi.org\/10.3390\/pathogens12091146.","journal-title":"Pathogens"},{"issue":"3","key":"8501_CR5","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s12072-011-9255-1","volume":"5","author":"T Goto","year":"2011","unstructured":"Goto T, Yoshida H, Tateishi R, Enooku K, Goto E, Sato T, et al. Influence of serum HBV DNA load on recurrence of hepatocellular carcinoma after treatment with percutaneous radiofrequency ablation. Hepatol Int. 2011;5(3):767\u201373.","journal-title":"Hepatol Int"},{"issue":"1","key":"8501_CR6","first-page":"31","volume":"23","author":"C Ayaz","year":"2015","unstructured":"Ayaz C, Celen MK, Dal T, Deveci O, Bayan K, Mert D, et al. Tenofovir disoproxil fumarate treatment in HbeAg-positive patients. Infez Med. 2015;23(1):31\u20135.","journal-title":"Infez Med"},{"key":"8501_CR7","doi-asserted-by":"publisher","first-page":"850747","DOI":"10.3389\/fcimb.2022.850747","volume":"12","author":"H Gao","year":"2022","unstructured":"Gao H, Xu L, Fan Z, Zhang X, Duan Z, Ren F. The role of autophagy in the mother-to-child transmission of pregnant women with a high level of HBV DNA. Front Cell Infect Microbiol. 2022;12:850747.","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"8501_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.33073\/pjm-2020-044","volume":"69","author":"M Guvenir","year":"2020","unstructured":"Guvenir M, Arikan A. Hepatitis B virus: from diagnosis to treatment. Pol J Microbiol. 2020;69(4):391\u20139.","journal-title":"Pol J Microbiol"},{"issue":"Suppl 1","key":"8501_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/liv.13010","volume":"36","author":"T He","year":"2016","unstructured":"He T, Jia J. Chronic HBV: which pregnant women should be treated? Liver Int. 2016;36(Suppl 1):105\u20138.","journal-title":"Liver Int"},{"issue":"34","key":"8501_CR10","doi-asserted-by":"publisher","first-page":"12056","DOI":"10.3748\/wjg.v20.i34.12056","volume":"20","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Chen C, Li Z, Wu YH, Xiao XM. Individualized management of pregnant women with high hepatitis B virus DNA levels. World J Gastroenterol. 2014;20(34):12056\u201361.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"8501_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/jvh.13628","volume":"29","author":"HL Chang","year":"2022","unstructured":"Chang HL, Wen WH, Lee CN, Chiu YE, Liu CJ, Chang MH, et al. Kinetics of hepatitis B surface antigen in pregnant women with and without Tenofovir disoproxil fumarate. J Viral Hepat. 2022;29(2):107\u201314.","journal-title":"J Viral Hepat"},{"issue":"5","key":"8501_CR12","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s12072-021-10235-1","volume":"15","author":"B Li","year":"2021","unstructured":"Li B, Liu Z, Liu X, Liu D, Duan M, Gu Y, et al. Efficacy and safety of tenofovir disoproxil fumarate and tenofovir alafenamide fumarate in preventing HBV vertical transmission of high maternal viral load. Hepatol Int. 2021;15(5):1103\u20138.","journal-title":"Hepatol Int"},{"issue":"2","key":"8501_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2169\/internalmedicine.3504-19","volume":"59","author":"M Suoh","year":"2020","unstructured":"Suoh M, Tamori A, Amano-Teranishi Y, Nakai T, Enomoto M, Kawasaki Y, et al. The administration of Tenofovir disoproxil fumarate for pregnant Japanese women with chronic hepatitis B. Intern Med. 2020;59(2):205\u201310.","journal-title":"Intern Med"},{"issue":"1","key":"8501_CR14","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3904\/kjim.2018.465","volume":"36","author":"YS Lee","year":"2021","unstructured":"Lee YS, Lee HS, Kim JH, Chang SW, Hyun MH, Bak H, et al. Role of tenofovir disoproxil fumarate in prevention of perinatal transmission of hepatitis B virus from mother to child: a systematic review and meta-analysis. Korean J Intern Med. 2021;36(1):76\u201385.","journal-title":"Korean J Intern Med"},{"issue":"10","key":"8501_CR15","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/j.cgh.2018.10.007","volume":"17","author":"J Hou","year":"2019","unstructured":"Hou J, Cui F, Ding Y, Dou X, Duan Z, Han G, et al. Management algorithm for interrupting Mother-to-Child transmission of hepatitis B virus. Clin Gastroenterol Hepatol. 2019;17(10):1929\u201336. e1.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"8501_CR16","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.clinre.2020.02.010","volume":"44","author":"MG Clemente","year":"2020","unstructured":"Clemente MG, Antonucci R, Sotgiu G, Dettori M, Piana A, Vajro P. Present and future management of viral hepatitis B and C in children. Clin Res Hepatol Gastroenterol. 2020;44(6):801\u20139.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"2","key":"8501_CR17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41575-020-00361-w","volume":"18","author":"NA Terrault","year":"2021","unstructured":"Terrault NA, Levy MT, Cheung KW, Jourdain G. Viral hepatitis and pregnancy. Nat Rev Gastroenterol Hepatol. 2021;18(2):117\u201330.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8501_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/genes9100469","author":"E Hadziyannis","year":"2018","unstructured":"Hadziyannis E, Laras A. Viral biomarkers in chronic HBeAg negative HBV infection. Genes (Basel). 2018. https:\/\/doi.org\/10.3390\/genes9100469.","journal-title":"Genes (Basel)"},{"issue":"5","key":"8501_CR19","first-page":"2091","volume":"27","author":"H Aladag","year":"2023","unstructured":"Aladag H, Aladag M. Is the use of tenofovir dipivoxil fumarate effective and safe in preventing vertical transmission in pregnant women with chronic HBV with high viral load? Eur Rev Med Pharmacol Sci. 2023;27(5):2091\u20138.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"8501_CR20","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1186\/s12889-024-20946-3","volume":"24","author":"L Bell","year":"2024","unstructured":"Bell L, Kalulu A, Ameara K, Allard N, Natuman S, Fisher Z, et al. Protektem pikinini blong yu trial: protocol for a single arm field trial to assess the effectiveness of treating-all pregnant women with hepatitis B infection with tenofovir prophylaxis to prevent mother-to-child transmission in Vanuatu, 2024\u20132025. BMC Public Health. 2024;24(1):3457.","journal-title":"BMC Public Health"},{"key":"8501_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/v14020434","author":"RN Chien","year":"2022","unstructured":"Chien RN, Liaw YF. Current trend in antiviral therapy for chronic hepatitis B. Viruses. 2022. https:\/\/doi.org\/10.3390\/v14020434.","journal-title":"Viruses"},{"issue":"1","key":"8501_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jinf.2015.09.038","volume":"72","author":"E Murakami","year":"2016","unstructured":"Murakami E, Tsuge M, Hiraga N, Kan H, Uchida T, Masaki K, et al. Effect of Tenofovir disoproxil fumarate on drug-resistant HBV clones. J Infect. 2016;72(1):91\u2013102.","journal-title":"J Infect"},{"issue":"1 Suppl","key":"8501_CR23","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1016\/j.jhep.2005.11.017","volume":"44","author":"A Hatzakis","year":"2006","unstructured":"Hatzakis A, Magiorkinis E, Haida C. HBV virological assessment. J Hepatol. 2006;44(1 Suppl):S71\u20136.","journal-title":"J Hepatol"},{"issue":"26","key":"8501_CR24","doi-asserted-by":"publisher","first-page":"126461","DOI":"10.1016\/j.vaccine.2024.126461","volume":"42","author":"M Arefaine","year":"2024","unstructured":"Arefaine M, Johannessen A, Teklehaymanot T, Mihret A, Alemayehu DH, Osman M, et al. A prospective, multicenter study of hepatitis B birth-dose vaccine with or without hepatitis B Immunoglobulin in preventing mother-to-child transmission of hepatitis B virus in Ethiopia. Vaccine. 2024;42(26):126461.","journal-title":"Vaccine"},{"key":"8501_CR25","doi-asserted-by":"publisher","DOI":"10.2196\/69838","volume":"9","author":"D Nguyen Tien","year":"2025","unstructured":"Nguyen Tien D, Thi Thu Bui H, Hoang Thi Ngoc T, Thi Pham T, Trung Nguyen D, Nguyen Thi Thu H, et al. A data-driven approach to assessing hepatitis B mother-to-child transmission risk prediction model: machine learning perspective. JMIR Form Res. 2025;9:e69838.","journal-title":"JMIR Form Res"},{"issue":"Suppl 1","key":"8501_CR26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/liv.13625","volume":"38","author":"S Shan","year":"2018","unstructured":"Shan S, Cui F, Jia J. How to control highly endemic hepatitis B in Asia. Liver Int. 2018;38(Suppl 1):122\u20135.","journal-title":"Liver Int"},{"issue":"8","key":"8501_CR27","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1111\/liv.15249","volume":"42","author":"G Samadi Kochaksaraei","year":"2022","unstructured":"Samadi Kochaksaraei G, Shaheen AA, Seow CH, Barkema HW, Coffin CS. Tenofovir disoproxil fumarate therapy to prevent hepatitis B virus vertical transmission-a review of maternal and infant outcomes. Liver Int. 2022;42(8):1712\u201330.","journal-title":"Liver Int"},{"key":"8501_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15873","author":"HL Chen","year":"2024","unstructured":"Chen HL, Lee CN, Chang CH, Lai MW, Tsai MC, Mu SC, et al. Tenofovir alafenamide or tenofovir disoproxil fumarate in pregnancy to prevent HBV transmission: maternal ALT trajectory and infant outcomes. Liver Int. 2024. https:\/\/doi.org\/10.1111\/liv.15873.","journal-title":"Liver Int"},{"key":"8501_CR29","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ejogrb.2022.07.009","volume":"276","author":"Z Li","year":"2022","unstructured":"Li Z, Xie B, Yi N, Cai H, Yi W, Gao X. Efficacy and safety of tenofovir disoproxil fumarate or telbivudine used throughout pregnancy for the prevention of mother-to-child transmission of hepatitis B virus: a cohort study. Eur J Obstet Gynecol Reprod Biol. 2022;276:102\u20136.","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-08501-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-025-08501-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-08501-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:04:05Z","timestamp":1767837845000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12884-025-08501-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8501"],"URL":"https:\/\/doi.org\/10.1186\/s12884-025-08501-3","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Central Hospital, Tianjin University\/Tianjin Third Central Hospital, with the informed consent having been waived. This study in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}